These studies evaluated IRF8 expression by TAMs and provide the first evidence that protein expression of this transcription factor is decreased in advanced stage patient specimens and can be used to predict long-term survival in a subset of ccRCC patients. Here, IRF8 is linked to nonpapillary renal cell carcinoma.